US2015283100A1PendingUtilityA1

Enterically coated cysteamine, cystamine and derivatives thereof

70
Assignee: UNIV CALIFORNIAPriority: Jan 27, 2006Filed: Nov 28, 2014Published: Oct 8, 2015
Est. expiryJan 27, 2026(expired)· nominal 20-yr term from priority
Inventors:Ranjan DohilJerry Schneider
A61P 39/06A61P 43/00A61P 3/00A61P 25/14A61P 25/16A61P 25/28A61P 25/00A61P 1/16A61K 9/1635A61K 9/2846A61K 31/194A61K 31/145A61K 9/5063A61K 9/5042A61K 9/5026A61K 9/2873A61K 9/0053A61K 9/5057A61K 31/13A61K 9/1605A61K 9/5047A61K 9/284A61K 9/2866A61K 9/4808A61K 9/288A61K 9/5005
70
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.

Claims

exact text as granted — not AI-modified
1 - 24 . (canceled) 
     
     
         25 . A method of treating cystinosis comprising administering a cysteamine composition twice per day.

Join the waitlist — get patent alerts

Track US2015283100A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.